Endo

Nevakar Injectables Announces the Launch of Ready-to-Use Ephedrine Injection Vials

Retrieved on: 
Monday, March 28, 2022
Endo International, Company, Anesthesiology, Life, LinkedIn, NASDAQ, Ephedrine, General manager, Senior, Health, Industry, Endo, MBA, GLOBE, Doctor of Nursing Practice, Par, Hypotension, FDA, Patient, Partnership, Pharmaceutical industry

Ephedrine is a widely used injectable vasopressor agent indicated for the treatment of clinically important hypotension occurring during surgery.

Key Points: 
  • Ephedrine is a widely used injectable vasopressor agent indicated for the treatment of clinically important hypotension occurring during surgery.
  • Ephedrine serves a very important role and is used by anesthesiologists, nurse anesthetists, and other health care professionals to treat hypotension during surgery, stated Sriram Ramanathan, MS, MBA, Chief Executive Officer of Nevakar Injectables.
  • Nevakar Injectables is developing a broad portfolio of injectable products for use in the hospital and ambulatory care settings.
  • The Company has active programs in critical patient care, acute pain management, long acting injectables, and hospital injectables.

Cardiol Therapeutics Appoints Jennifer M. Chao to Its Board of Directors

Retrieved on: 
Tuesday, March 15, 2022
Harvard Medical School, RBC Capital Markets, Therapy, Risk, CVD, Corporate governance, Partner, CRDL, Patient, News, Board of directors, Acquisition, Heart failure, Director, FDA, Cardiovascular disease, Wall Street, COVID-19, LLC, Audit committee, Intellectual Property Committee, Safety, History, Financial compensation, Endo International, Deutsche Bank, NASDAQ, Degenerative disease, Investigational New Drug, Endo, Board, Company, Research, Inflammation, CGMP, Heart, Industry, Biotechnology, TSX, VP, Massachusetts General Hospital, Pharmaceutical industry, Management, New York University, Politics

Ms. Chao has over 25 years of experience in the biotech and life sciences industries focused primarily on finance and corporate strategy.

Key Points: 
  • Ms. Chao has over 25 years of experience in the biotech and life sciences industries focused primarily on finance and corporate strategy.
  • She currently serves on the Board of Directors of Endo Pharmaceuticals and is a member of the Audit Committee and Compliance Committee.
  • "We are thrilled that Jennifer has agreed to join our Board of Directors," said Dr. Guillermo Torre, Chairman of Cardiol Therapeutics.
  • Iain Chalmers has stepped down from the Board of Directors to accommodate Ms. Chao's appointment.

Endometriosis Research Funding Bill Passed in Congress

Retrieved on: 
Saturday, March 12, 2022
White House, Federal Government, Public Policy, Healthcare Reform, Pharmaceutical, Surgery, Women, Philanthropy, Congressional News, Views, Public Policy, Government, Foundation, Biotechnology, Science, Other Science, Consumer, Research, Health, Attention, Endometriosis Foundation of America, Upendo Ni Pamoja, Pelvic pain, National Institute, Human development, NICHD, Economic policy of the Joe Biden administration, Congress, Department, Defense, Research, Rest, Hope, Federation, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Endometriosis, Education, Quality of life, Appendix, Endo, United States House Caucus on Missing and Exploited Children, Actor, Pain, United States Senate, News, Host, PCOS, Woman, Infertility, Uterus, Candidate, Ovarian cancer, House, Patient, Neoplasm, Senate, Female, Disease, GA, Legislation, Awareness, Diagnosis, Department of Defense Appropriations Act, 2015, Pharmaceutical industry

This means that NICHD can increase the amount of endometriosis research they fund, and the Department of Defense will continue to fund research on endometriosis among a select group of priority research areas.

Key Points: 
  • This means that NICHD can increase the amount of endometriosis research they fund, and the Department of Defense will continue to fund research on endometriosis among a select group of priority research areas.
  • Endometriosis Foundation of America has been working tirelessly since its inception to increase federal research funding for a disease that affects millions of Americans.
  • Now, thanks to the work of so many -- Congress is finally prioritizing endometriosis!
  • EndoFound is the countrys largest non-profit 501(c)(3) organization dedicated to increasing disease recognition, providing advocacy, facilitating expert surgical training, and funding landmark research for endometriosis.

Right on Brands, Inc. Reports Record 3rd Quarter and New Store in Laredo, Texas

Retrieved on: 
Wednesday, February 9, 2022
ENDO, Drink, GLOBE, Industry, OTC, THC, Hemp, Oil, CBDV, CBD, City, Heart, HHC, Â, Foodservice, Dispensary, Arena Plaza, SEC, CEO, Health, Music, Food, Laredo, Texas, Wellness, THCV, Endo, Pharmaceutical industry, Retail

Jerry Grisaffi, CEO said, This is the second record quarter in a row for the company and it confirms that the company is on the right path and set for growth.

Key Points: 
  • Jerry Grisaffi, CEO said, This is the second record quarter in a row for the company and it confirms that the company is on the right path and set for growth.
  • This second store in operation to allow us to introduce Endo to a whole new group of consumers in South Texas.
  • We have look at many product lines truly believe Endo is the Best and are super excited to represent this line.
  • store opening will increase corporate cash flow and allow the company to buy down debt at the fastest rate in corporate history.

Omnia Wellness to Penetrate the $20B Chiropractic Industry, Management Will Attend Parker Seminars Las Vegas 2022 Event on Feb. 10-12

Retrieved on: 
Tuesday, February 8, 2022
Motivation, Name, Pandemic, Relaxation, Epidemic, Philosophy, Time, Solution, Company, Marketing, Technology, Vibration, Learning, Risk, Health, Ebony Horsewomen, Inc. Equestrian and Therapeutic Center, Massage, Disease, Education, Communication, Endo, COVID-19, Healthcare, Risk management, Chiropractic

Parker Seminars Las Vegas 2022 will have approximately 3,200 people in attendance and is recognized as the largest gathering of chiropractors, chiropractic assistants and chiropractic vendors in the world.

Key Points: 
  • Parker Seminars Las Vegas 2022 will have approximately 3,200 people in attendance and is recognized as the largest gathering of chiropractors, chiropractic assistants and chiropractic vendors in the world.
  • Parker Seminars embrace the entire profession, regardless of ones philosophy or techniques.
  • In addition, the seminars include the largest expo in the profession, where vendors display the latest industry products and technologies.
  • International Parker Seminars are made possible through professional alliances with international organizations, in effort to raise funds for chiropractic research and education and advance chiropractic in those countries.

Endo to Announce Fourth Quarter and Full-Year 2021 Financial Results

Retrieved on: 
Tuesday, January 25, 2022
Endo, International, Endo International, Life, Webcast, NASDAQ, LinkedIn, Company, Pharmaceutical industry

DUBLIN, Jan. 25, 2022 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) will announce its fourthquarter and full-year 2021 financial results on February 28, 2022 and members of its senior management team will host a conference call and webcast on March 1, 2022 at 7:30am ET before the U.S. financial markets open.

Key Points: 
  • DUBLIN, Jan. 25, 2022 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) will announce its fourthquarter and full-year 2021 financial results on February 28, 2022 and members of its senior management team will host a conference call and webcast on March 1, 2022 at 7:30am ET before the U.S. financial markets open.
  • The dial-in number to access the call is U.S./Canada (866) 497-0462, International (678) 509-7598, and the passcode is 4272796.
  • In addition, a replay of the webcast will be available on the Company website for one year following the event.
  • Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies.

Endo to Announce Fourth Quarter and Full-Year 2021 Financial Results

Retrieved on: 
Tuesday, January 25, 2022
Endo, International, Endo International, Life, Webcast, NASDAQ, LinkedIn, Company, Pharmaceutical industry

DUBLIN, Jan. 25, 2022 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) will announce its fourthquarter and full-year 2021 financial results on February 28, 2022 and members of its senior management team will host a conference call and webcast on March 1, 2022 at 7:30am ET before the U.S. financial markets open.

Key Points: 
  • DUBLIN, Jan. 25, 2022 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) will announce its fourthquarter and full-year 2021 financial results on February 28, 2022 and members of its senior management team will host a conference call and webcast on March 1, 2022 at 7:30am ET before the U.S. financial markets open.
  • The dial-in number to access the call is U.S./Canada (866) 497-0462, International (678) 509-7598, and the passcode is 4272796.
  • In addition, a replay of the webcast will be available on the Company website for one year following the event.
  • Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies.

Cobbs Creek Healthcare Hires Global Pharmaceutical Industry Leader Vince Mair as President

Retrieved on: 
Thursday, January 20, 2022
Specialization, Algorithm, Endo, Neos, Growth, Solution, Mair, BMS, Therapy, Software as a service, Service, Data science, Business, Jun, Investment, Pharmaceutical industry

NEWTOWN SQUARE, Pa., Jan. 20, 2022 /PRNewswire/ -- Cobbs Creek Healthcare , a data science and advanced analytics firm transforming healthcare decision-making through innovative insights and a specialization in ML/AI, announces global pharmaceutical industry leader Vince Mair has joined the company as President.

Key Points: 
  • NEWTOWN SQUARE, Pa., Jan. 20, 2022 /PRNewswire/ -- Cobbs Creek Healthcare , a data science and advanced analytics firm transforming healthcare decision-making through innovative insights and a specialization in ML/AI, announces global pharmaceutical industry leader Vince Mair has joined the company as President.
  • Mair will take over day-to-day leadership responsibilities, build out Cobbs Creek Healthcare's leadership team, and apply Cobbs Creek's core intellectual platforms to help clients improve their business decisions and investments.
  • Cobbs Creek Healthcare is a data analytics firm enabling the pharmaceutical industry to make better decisions and improve their business results from lab to market.
  • Cobbs Creek was named to CIO Review's list of Top 10 Healthcare Consulting & Service Companies for 2021.

Omnia Wellness Completes Pivotal Step to Enter European Athletic Market with the Swiss Gymnastics Federation (STV)

Retrieved on: 
Tuesday, January 18, 2022
Association, Swiss Gymnastics Federation, Volleyball, Technology, Intention, STV, Evilard, COVID-19, Endo, Massage, Letter, Population, Relaxation, Central, Swiss Federal Institute of Aquatic Science and Technology, Disease, Athlete, Vibration, Solution, GLOBE, Basketball, Movement, Health, Pandemic, Time, OTC, Ebony Horsewomen, Inc. Equestrian and Therapeutic Center, Company, Epidemic, Swiss Olympic Association, Gymnastics, Federation, Wheel gymnastics, Risk, Sports equipment, Pharmaceutical industry, EU, Swiss, Omnia

DENVER, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Omnia Wellness Inc. (the “Company”) (OTC US: OMWS), a health and wellness company providing advanced wellness and fitness therapeutic technologies has completed a pivotal step to enter the European athletic market by signing a Letter of Intent with the Swiss Gymnastics Federation (Schweizerischer Turnverband or STV).

Key Points: 
  • The Swiss Gymnastics Federation (STV), founded in 1985 and headquartered in Aarau, is the umbrella organization of cantonal/regional associations, gymnastics clubs, and is a member of the Swiss Olympic Association.
  • The STV promotes top-class sport (artistic gymnastics, rhythmic gymnastics and trampoline) as well as popular sports (aerobics, gymnastics, Rhonrad, fistball, Indiaca, basketball, and volleyball).
  • The Federation has a long history of serving the health and wellness of its athletes for over 180 years.
  • Founded in 1985 and headquartered in Aarau, the Swiss Gymnastics Federation (STV), is the umbrella organization of cantonal/regional associations, gymnastics clubs, and is a member of the Swiss Olympic Association.

Endo to Participate at J.P. Morgan 40th Annual Healthcare Conference

Retrieved on: 
Tuesday, January 4, 2022
EST, Company, Endo, NASDAQ, Endo International, LinkedIn, Life, Conference, Pharmaceutical industry

DUBLIN, Jan. 4, 2022 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 8:15 a.m. EST.

Key Points: 
  • DUBLIN, Jan. 4, 2022 /PRNewswire/ --Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 8:15 a.m. EST.
  • A live webcast and audio archive for the event will be available on the Company's website at http://investor.endo.com/events-and-presentations .
  • Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies.
  • Our decades of proven success come from a global team of passionate team members collaborating to bring the best treatments forward.